Catalyst

Slingshot members are tracking this event:

Additional Phase 2b data of Medicinova's(MNOV) MN-166 in Progressive multiple sclerosis to be presented at AAN meeting May 6, 2019 at 2:06 PM ET

Source Link:
https://investors.medicinova.com/news-releases/news-release-details/medicinova-announces-upcoming-presentations-regarding-sprint-ms?ID=2392143&c=183833&p=irol-newsArticle

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
MNOV Community voting in process
SIGN ME UP
I want to vote! LOG ME IN
Now!
Slingshot Insights Explained
JOIN FOR FREE TODAY
Catalyst Date
Occurred on:
May 07, 2019
Occurred Source:
https://www.globenewswire.com/news-release/2019/05/07/1818966/0/en/MediciNova-Participated-in-the-RECEDE-Phase-3-Degenerative-Cervical-Myelopathy-Trial-Kick-off-Meeting-DCM-Symposium-and-the-Official-Launch-of-Myelopathy-org-in-London-United-Kingd.html
Related Projects Image

  • Don’t see a project related to the catalyst you care about?

Related Keywords Mn-166, Progressive Multiple Sclerosis, Aan 2019
About Us
Media Center
Connect with Us
© 2024 Slingshot Insights. All rights reserved.